The interaction between human urotensin II and vasodilator agents in human internal mammary artery with possible clinical implications

Annals of Thoracic Surgery

Volumn 92, Issue 2, 2011, Pages 610-616

  Bai, Xiao Yan ^a,b,c   Liu, Xiao Cheng ^a,b,c   Yang, Qin ^a,b,c   Tang, Xiang Dong ^a,b,c   He, Guo Wei ^a,b,c  

^a NANKAI UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST; CILNIDIPINE; DILTIAZEM; GLYCERYL TRINITRATE; NICARDIPINE; NIFEDIPINE; POTASSIUM CHLORIDE; URANTIDE; UROTENSIN II; VASODILATOR AGENT;

ARTERY CONSTRICTION; ARTICLE; BLOOD; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG POTENCY; HEART CONTRACTION; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MYOGRAPHY; PRIORITY JOURNAL;

CALCIUM CHANNEL BLOCKERS; CORONARY VASOSPASM; DILTIAZEM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MAMMARY ARTERIES; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL REVASCULARIZATION; NIFEDIPINE; NITROGLYCERIN; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; RECEPTORS, G-PROTEIN-COUPLED; UROTENSINS; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 79960969435     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.03.094     Document Type: Article

References (39)

1. G.W. He, and Z.G. Liu Comparison of nitric oxide release and endothelium-derived hyperpolarizing factor-mediated hyperpolarization between human radial and internal mammary arteries Circulation 104 12 Suppl 1 2001 I344 I349
2. M.R. Sarabu, J.A. McClung, A. Fass, and G.E. Reed Early postoperative spasm in left internal mammary artery bypass grafts Ann Thorac Surg 44 1987 199 200 (Pubitemid 17119325)
3. G.W. He Arterial grafts for coronary artery bypass grafting: biological characteristics, functional classification, and clinical choice Ann Thorac Surg 67 1999 277 284
4. G.W. Stone, and G.O. Hartzler Spontaneous reversible spasm in an internal mammary artery graft causing acute myocardial infarction Am J Cardiol 64 1989 822 823 (Pubitemid 19237979)
5. H. Kitamura, K. Nakayama, and T. Kitano A case of refractory spasm of multiple coronary arteries and left internal thoracic artery graft following off-pump CABG [Article in Japanese] Kyobu Geka 54 2001 1103 1106
6. Y. Coulouarn, I. Lihrmann, and S. Jegou Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord Proc Natl Acad Sci U S A 95 1998 15803 15808 (Pubitemid 29018781)
7. Y.C. Zhu, Y.Z. Zhu, and P.K. Moore The role of urotensin II in cardiovascular and renal physiology and diseases Br J Pharmacol 148 2006 884 901 (Pubitemid 44543606)
8. S.A. Douglas, D. Dhanak, and D.G. Johns From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function Trends Pharmacol Sci 25 2004 76 85 (Pubitemid 38183393)
9. T. Watanabe, K. Takahashi, and T. Kanome Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide Hypertens 29 2006 821 831 (Pubitemid 44842818)
10. G.W. He, J.A. Angus, and F.L. Rosenfeldt Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: relevance to coronary bypass graft surgery J Cardiovasc Pharmacol 12 1988 12 22
11. G.W. He, F.L. Rosenfeldt, B.F. Buxton, and J.A. Angus Reactivity of human isolated internal mammary artery to constrictor and dilator agents Implications for treatment of internal mammary artery spasm Circulation 80 3 Pt 1 1989 I141 I150
12. R. Patacchini, P. Santicioli, and S. Giuliani Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta Br J Pharmacol 140 2003 1155 1158 (Pubitemid 38117417)
13. C.D. Furberg, B.M. Psaty, and J.V. Meyer Nifedipine Dose-related increase in mortality in patients with coronary heart disease Circulation 92 1995 1326 1331
14. L.H. Opie, and F.H. Messerli Nifedipine and mortality Grave defects in the dossier Circulation 92 1995 1068 1073
15. G.W. He, L. Fan, A. Furnary, and Q. Yang A new antispastic solution for arterial grafting: nicardipine and nitroglycerin cocktail in preparation of internal thoracic and radial arteries for coronary surgery J Thorac Cardiovasc Surg 136 2008 673 680 680.e12
16. L. Fan, Q. Yang, and X.Q. Xiao Dual actions of cilnidipine in human internal thoracic artery: Inhibition of calcium channels and enhancement of endothelial nitric oxide synthase J Thorac Cardiovasc Surg 141 2011 1063 1069
17. X.Y. Bai, X.C. Liu, W.B. Jing, Q. Yang, X.D. Tang, and G.W. He Effect of amlodipine in human internal mammary artery and clinical implications Ann Thorac Surg 90 2010 1952 1957
18. Z.W. Chen, Q. Yang, Y. Huang, L. Fan, X.W. Li, and G.W. He Human urotensin II in internal mammary and radial arteries of patients undergoing coronary surgery Vascul Pharmacol 52 2010 70 76
19. M.H. Liu, H. Jin, H.S. Floten, Z. Ren, A.P. Yim, and G.W. He Vascular endothelial growth factor-mediated, endothelium-dependent relaxation in human internal mammary artery Ann Thorac Surg 73 2002 819 824 (Pubitemid 34188321)
20. L. Sasson, A.J. Cohen, E. Hauptman, and A. Schachner Effect of topical vasodilators on internal mammary arteries Ann Thorac Surg 59 1995 494 496
21. G.W. He, C.Q. Yang, and A. Starr Overview of the nature of vasoconstriction in arterial grafts for coronary operations Ann Thorac Surg 59 1995 676 683
22. S.W. Downing, and L.H. Edmunds Jr Release of vasoactive substances during cardiopulmonary bypass Ann Thorac Surg 54 1992 1236 1243 (Pubitemid 23000130)
23. W. Wei, C.Q. Yang, A. Furnary, and G.W. He Greater vasopressin-induced vasoconstriction and inferior effects of nitrovasodilators and milrinone in the radial artery than in the internal thoracic artery J Thorac Cardiovasc Surg 129 2005 33 40 (Pubitemid 40038093)
24. A. Shenouda, S.A. Douglas, E.H. Ohlstein, and A. Giaid Localization of urotensin-II immunoreactivity in normal human kidneys and renal carcinoma J Histochem Cytochem 50 2002 885 889 (Pubitemid 34774599)
25. J.J. Maguire, R.E. Kuc, K.E. Wiley, M.J. Kleinz, and A.P. Davenport Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries Peptides 25 2004 1767 1774 (Pubitemid 39346219)
26. M. Matsushita, M. Shichiri, and T. Imai Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues J Hypertens 19 2001 2185 2190 (Pubitemid 33135240)
27. R.S. Ames, H.M. Sarau, and J.K. Chambers Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 Nature 401 1999 282 286
28. L.L. Ng, I. Loke, R.J. O'Brien, I.B. Squire, and J.E. Davies Plasma urotensin in human systolic heart failure Circulation 106 2002 2877 2880 (Pubitemid 35424734)
29. A.M. Richards, M.G. Nicholls, J.G. Lainchbury, S. Fisher, and T.G. Yandle Plasma urotensin II in heart failure Lancet 360 2002 545 546 (Pubitemid 35232110)
30. F.D. Russell, D. Meyers, and A.J. Galbraith Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure Am J Physiol Heart Circ Physiol 285 2003 H1576 H1581
31. M. Heringlake, T. Kox, and O. Uzun The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease Regul Pept 121 2004 129 136 (Pubitemid 38901071)
32. J.P. Thompson, P. Watt, S. Sanghavi, J.W. Strupish, and D.G. Lambert A comparison of cerebrospinal fluid and plasma urotensin II concentrations in normotensive and hypertensive patients undergoing urological surgery during spinal anesthesia: a pilot study Anesth Analg 97 2003 1501 1503 (Pubitemid 37310156)
33. B.M. Cheung, R. Leung, Y.B. Man, and L.Y. Wong Plasma concentration of urotensin II is raised in hypertension J Hypertens 22 2004 1341 1344 (Pubitemid 38888080)
34. C. Hillier, C. Berry, and M.C. Petrie Effects of urotensin II in human arteries and veins of varying caliber Circulation 103 2001 1378 1381 (Pubitemid 32220627)
35. J. Paysant, A. Rupin, S. Simonet, J.N. Fabiani, and T.J. Verbeuren Comparison of the contractile responses of human coronary bypass grafts and monkey arteries to human urotensin-II Fundam Clin Pharmacol 15 2001 227 231 (Pubitemid 32939490)
36. T. Hirose, K. Takahashi, and N. Mori Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1 Peptides 30 2009 1124 1129
37. T. Watanabe, S. Arita, and Y. Shiraishi Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases Curr Med Chem 16 2009 550 563
38. G.W. He, C.Q. Yang, M.J. Mack, T.E. Acuff, W.H. Ryan, and A. Starr Interaction between endothelin and vasodilators in the human internal mammary artery Br J Clin Pharmacol 38 1994 505 512 (Pubitemid 24365858)
39. G.W. He Contractility of the human internal mammary artery at the distal section increases toward the end Emphasis on not using the end of the internal mammary artery for grafting J Thorac Cardiovasc Surg 106 1993 406 411